Discontinuation report SANDOSTATIN
Report ID | 223070 |
Drug Identification Number | 00839205 |
Brand name | SANDOSTATIN |
Common or Proper name | SANDOSTATIN 100UG 1ML 1 X 5 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | OCTREOTIDE |
Strength(s) | 100MCG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 1 X 5 |
ATC code | H01CB |
ATC description | HYPOTHALAMIC HORMONES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-02-05 |
Actual discontinuation date | 2024-02-05 |
Remaining supply date | 2025-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-03-22 | French | Compare |
v2 | 2024-03-22 | English | Compare |
v1 | 2024-03-22 | English | Compare |
Showing 1 to 3 of 3